| Year |
Citation |
Score |
| 2023 |
Sengupta S, Zhang J, Reed MC, Yu J, Kim A, Boronina TN, Board NL, Wrabl JO, Shenderov K, Welsh RA, Yang W, Timmons AE, Hoh R, Cole RN, Deeks SG, et al. A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design. The Journal of Experimental Medicine. 220. PMID 37058141 DOI: 10.1084/jem.20221654 |
0.787 |
|
| 2020 |
Song N, Sengupta S, Khoruzhenko S, Welsh RA, Kim A, Kumar MR, Sønder SU, Sidhom JW, Zhang H, Jie C, Siliciano RF, Sadegh-Nasseri S. Multiple genetic programs contribute to CD4 T cell memory differentiation and longevity by maintaining T cell quiescence. Cellular Immunology. 357: 104210. PMID 32987276 DOI: 10.1016/J.Cellimm.2020.104210 |
0.713 |
|
| 2019 |
Kim A, Ishizuka IE, Hartman IZ, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC Class II Peptide Loading and Editing In Vitro. Methods in Molecular Biology (Clifton, N.J.). 1988: 343-355. PMID 31147951 DOI: 10.1007/978-1-4939-9450-2_24 |
0.813 |
|
| 2018 |
Sadegh-Nasseri S, Kim A. Selection of immunodominant epitopes during antigen processing is hierarchical. Molecular Immunology. PMID 30146122 DOI: 10.1016/J.Molimm.2018.08.011 |
0.862 |
|
| 2017 |
Kim A, Boronina TN, Cole RN, Darrah E, Sadegh-Nasseri S. Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing. Scientific Reports. 7: 46418. PMID 28422163 DOI: 10.1038/Srep46418 |
0.792 |
|
| 2016 |
Darrah E, Kim A, Zhang X, Boronina T, Cole RN, Fava A, Giles JT, Bingham Iii CO, Chalmers MJ, Griffin PR, Sadegh-Nasseri S, Rosen A. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis. Journal of Proteome Research. PMID 27700100 DOI: 10.1021/Acs.Jproteome.6B00617 |
0.82 |
|
| 2015 |
Sadegh-Nasseri S, Kim A. MHC Class II Auto-Antigen Presentation is Unconventional. Frontiers in Immunology. 6: 372. PMID 26257739 DOI: 10.3389/Fimmu.2015.00372 |
0.852 |
|
| 2015 |
Sadegh-Nasseri S, Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Molecular Immunology. 68: 81-4. PMID 26254987 DOI: 10.1016/J.Molimm.2015.07.018 |
0.855 |
|
| 2015 |
Kim A, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Current Opinion in Immunology. 34: 9-15. PMID 25576665 DOI: 10.1016/J.Coi.2014.12.005 |
0.835 |
|
| 2014 |
Kim A, Hartman IZ, Poore B, Boronina T, Cole RN, Song N, Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nature Communications. 5: 5369. PMID 25413013 DOI: 10.1038/Ncomms6369 |
0.834 |
|
| 2013 |
Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and Its Role in MHC Class II Antigen Presentation. Frontiers in Immunology. 4: 260. PMID 24009612 DOI: 10.3389/Fimmu.2013.00260 |
0.86 |
|
| 2013 |
Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. Plos One. 8: e71228. PMID 23951115 DOI: 10.1371/Journal.Pone.0071228 |
0.842 |
|
| 2013 |
Kim TH, Swierczewska M, Oh Y, Kim A, Jo DG, Park JH, Byun Y, Sadegh-Nasseri S, Pomper MG, Lee KC, Lee S. Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo. Angewandte Chemie (International Ed. in English). 52: 6880-4. PMID 23740787 DOI: 10.1002/Anie.201302181 |
0.737 |
|
| 2013 |
Kim A, Ishizuka I, Hartman I, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC class II peptide loading and editing in vitro. Methods in Molecular Biology (Clifton, N.J.). 960: 447-59. PMID 23329506 DOI: 10.1007/978-1-62703-218-6_33 |
0.812 |
|
| 2013 |
Kim TH, Swierczewska M, Oh Y, Kim A, Jo DG, Park JH, Byun Y, Sadegh-Nasseri S, Pomper MG, Lee KC, Lee S. Rücktitelbild: Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo (Angew. Chem. 27/2013) Angewandte Chemie. 125: 7182-7182. DOI: 10.1002/Ange.201304233 |
0.731 |
|
| 2012 |
Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Frontiers in Bioscience (Scholar Edition). 4: 1325-32. PMID 22652874 DOI: 10.2741/S334 |
0.855 |
|
| 2012 |
Sadegh-Nasseri S, Poluektov Y, Kim A. Understanding how HLA-DO works Molecular Immunology. 51: 29. DOI: 10.1016/J.Molimm.2012.02.080 |
0.789 |
|
| 2010 |
Hartman IZ, Kim A, Cotter RJ, Walter K, Dalai SK, Boronina T, Griffith W, Lanar DE, Schwenk R, Krzych U, Cole RN, Sadegh-Nasseri S. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nature Medicine. 16: 1333-40. PMID 21037588 DOI: 10.1038/Nm.2248 |
0.829 |
|
| 2010 |
Sadegh-Nasseri S, Natarajan S, Chou CL, Hartman IZ, Narayan K, Kim A. Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection. Immunologic Research. 47: 56-64. PMID 20066513 DOI: 10.1007/S12026-009-8138-1 |
0.831 |
|
| 2008 |
Chou CL, Mirshahidi S, Su KW, Kim A, Narayan K, Khoruzhenko S, Xu M, Sadegh-Nasseri S. Short peptide sequences mimic HLA-DM functions. Molecular Immunology. 45: 1935-43. PMID 18054387 DOI: 10.1016/J.Molimm.2007.10.033 |
0.827 |
|
| 2007 |
Narayan K, Chou CL, Kim A, Hartman IZ, Dalai S, Khoruzhenko S, Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nature Immunology. 8: 92-100. PMID 17143275 DOI: 10.1038/Ni1414 |
0.798 |
|
| Show low-probability matches. |